Tyra Biosciences' (TYRA) Outperform Rating Reaffirmed at Wedbush

Wedbush reissued their outperform rating on shares of Tyra Biosciences (NASDAQ:TYRA – Free Report) in a research note published on Thursday, Benzinga reports. Wedbush currently has a $28.00 target price on the stock. Other equities analysts have also issued reports about the stock. HC Wainwright reaffirmed a buy rating and issued a $23.00 price objective […]

Related Keywords

United States ,America ,Daniel Bensen ,Tyra Biosciences ,Securities Exchange Commission ,Exchange Traded Concepts ,Tyra Biosciences Inc ,Driehaus Capital Management ,Corton Capital Inc ,Simplex Trading ,York Mellon Corp ,Free Report ,Biosciences Stock Down ,Exchange Commission ,Traded Concepts ,New York Mellon Corp ,Capital Management ,Get Free Report ,Tyra Biosciences Daily ,Nasdaq Tyra ,Styra ,Medical ,Reiterated Rating ,Wedbush ,